Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) is held by 103 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | -139,832 | -13.60% | $0.00 |
| NEA Management Company, LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| T. Rowe Price Investment Management, Inc. | 31 Dec, 2025 | 0 | 2,194,714 | 20.43% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -26,209 | -25.94% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Siren, L.L.C. | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | 26,421 | 100.00% | $0.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 0 | 1,149,050 | 238.83% | $0.00 |
| Vestal Point Capital, LP | 31 Dec, 2025 | 0 | -4,680,000 | -84.32% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 200 | 100.00% | $0.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 0 | -189,120 | -14.56% | $0.00 |
| WINTON GROUP Ltd | 31 Dec, 2025 | 0 | 421,280 | 0.00% | $0.00 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 31 Dec, 2025 | 0 | 143,615 | 16.01% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | -370,783 | -59.00% | $0.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 0 | 724,503 | 305.35% | $0.00 |
| RITHOLTZ WEALTH MANAGEMENT | 31 Dec, 2025 | 0 | 126,391 | 124.55% | $0.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 0 | 350,335 | 58.45% | $0.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 0 | 196,741 | 0.00% | $0.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 0 | 401,145 | 88.00% | $0.00 |
| Qube Research & Technologies Ltd | 31 Dec, 2025 | 0 | 91,352 | 116.72% | $0.00 |